(EMAILWIRE.COM, December 27, 2017 ) The Middle East and Africa Intrauterine devices (IUD’S) Market was worth $ 238 million in 2016 and estimated to reach $ 300 million by the end of 2021 with a growing potential of 4.715 %.

The intrauterine device (IUD) is most used for reversible family planning method across the world. The earlier IUDs made up of inert plastic materials have largely been archaic in modern practice by products which release levonorgestrel or copper, modifications which significantly enhance high efficacy. The intrauterine contraceptive device is a safe, effective and convenient contraceptive method. The use of IUDs has been limited in less developed countries due to increase in menstrual blood loss which has been a significant issue. So, the most population has been preferred to use the levonorgestrel releasing IUD (LNg IUD) which is highly effective, long-lasting and reduces the blood loss during menstruation in less developed countries.

Full report at: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-intrauterine-devices-market-1097/

Technical innovations, increasing prevalence of STD’S (Sexually transmitted diseases), direct health benefits other than birth control, increasing government initiatives to prevent unwanted abortions and pregnancies are driving the growth of the market in Middle East and Africa. The factors that are hampering the growth of the market are issues of Infertility, Side effects, ectopic pregnancy, pelvic inflammatory infection, and Limited access to contraception.

The Middle East and Africa intrauterine Devices market is broadly categorized based on product type into Hormonal intrauterine device and Copper intrauterine device.

Request sample: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-intrauterine-devices-market-1097/request-sample

Major players influencing the Middle East and Africa intrauterine devices market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer AG, Teva Pharmaceutical, Pfizer, Mylan laboratories, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc.

About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results